EDSA Edesa Biotech Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: EDSA

Price (delayed)

$4.633

Market cap

$14.69M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.63

Enterprise value

$10.51M

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05 ...

Highlights
Edesa Biotech's EPS has soared by 62% YoY and by 10% from the previous quarter
EDSA's net income has soared by 50% year-on-year and by 8% since the previous quarter
The quick ratio has shrunk by 62% YoY and by 23% QoQ
The equity has declined by 43% year-on-year and by 17% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.edesabiotech.com
Peers: OMER OMGA

Key stats

What are the main financial stats of EDSA
Market
Shares outstanding
3.17M
Market cap
$14.69M
Enterprise value
$10.51M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.51
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$7.72M
EBITDA
-$7.52M
Free cash flow
-$6.25M
Per share
EPS
-$2.63
Free cash flow per share
-$2
Book value per share
$1.85
Revenue per share
$0
TBVPS
$1.81
Balance sheet
Total assets
$7.83M
Total liabilities
$1.99M
Debt
$78,314
Equity
$5.84M
Working capital
$3.43M
Liquidity
Debt to equity
0.01
Current ratio
2.73
Quick ratio
2.52
Net debt/EBITDA
0.56
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-83.9%
Return on equity
-103.8%
Return on invested capital
N/A
Return on capital employed
-132%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EDSA stock price

How has the Edesa Biotech stock price performed over time
Intraday
1.6%
1 week
7%
1 month
0.94%
1 year
-40.91%
YTD
1.38%
QTD
10.52%

Financial performance

How have Edesa Biotech's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.7M
Net income
-$7.72M
Gross margin
N/A
Net margin
N/A
EDSA's net income has soared by 50% year-on-year and by 8% since the previous quarter
Edesa Biotech's operating income has increased by 44% YoY and by 6% from the previous quarter

Growth

What is Edesa Biotech's growth rate over time

Valuation

What is Edesa Biotech stock price valuation
P/E
N/A
P/B
2.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Edesa Biotech's EPS has soared by 62% YoY and by 10% from the previous quarter
EDSA's price to book (P/B) is 44% lower than its 5-year quarterly average of 4.5 but 20% higher than its last 4 quarters average of 2.1
The equity has declined by 43% year-on-year and by 17% since the previous quarter

Efficiency

How efficient is Edesa Biotech business performance
The company's return on equity rose by 19% YoY but it fell by 6% QoQ
Edesa Biotech's return on assets has increased by 17% YoY

Dividends

What is EDSA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EDSA.

Financial health

How did Edesa Biotech financials performed over time
EDSA's current ratio has shrunk by 62% YoY and by 23% QoQ
The quick ratio has shrunk by 62% YoY and by 23% QoQ
EDSA's debt is 99% smaller than its equity
EDSA's debt is down by 47% year-on-year and by 17% since the previous quarter
The equity has declined by 43% year-on-year and by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.